Medical Bulletin 18/August/2026

Here are the top medical news for today:

Study of 720,000 Adults Links Artificial Sweeteners to Higher Diabetes Risk

A new systematic review and meta-analysis suggest that adults who consume higher amounts of artificial sweeteners may face a greater risk of developing type 2 diabetes (T2D). The findings, published in Frontiers in Nutrition, add to an ongoing debate over whether sugar substitutes are truly metabolically neutral over the long term.

Researchers analyzed six prospective cohort studies involving 721,003 adults from the US, Japan and Europe, with participants followed for an average of 10.1 years. During that period, 38,445 cases of T2D were recorded.

Compared with people reporting little or no artificial sweetener consumption, those with higher intake had a 31% higher relative risk of developing T2D. The analysis included major cohorts such as NutriNet-Santé, EPIC-InterAct, MESA, the Japanese JPHC study, the Health Professionals Follow-up Study, and the Nurses’ Health Studies.

However, the researchers stressed that the findings do not prove artificial sweeteners cause diabetes. All included studies were observational, meaning other factors could partly explain the association. Artificial sweetener consumption may also be more common among people who already have obesity or other metabolic risk factors.

The researchers pointed to several possible biological explanations, including changes in the gut microbiome, insulin sensitivity, intestinal barrier function, inflammation, and pathways involved in appetite and energy regulation.

Importantly, the certainty of evidence was rated low, partly because only six studies were available and results varied substantially between them.

The findings therefore do not mean that artificial sweeteners should automatically be avoided. Instead, they highlight the need for more long-term randomized research to determine whether replacing sugar with artificial sweeteners actually improves metabolic health.

For now, the bigger takeaway may be simple: swapping sugar for sweetness alone may not be enough—overall diet quality still matters.

REFERENCE: Lu, S., Lu, Y., Xu, R., Hou, W., Xu, T., & Tang, W. (2026). The longitudinal association between artificial sweetener intake and the risk of type 2 diabetes among adults aged 18 years and older: A systematic review and meta-analysis. Frontiers in Nutrition, 13, 1886458. DOI: 10.3389/fnut.2026.1886458

Low-Fiber Diet May Drive Gut Microbes to Consume the Intestinal Lining: Study

Plant foods may influence gut health in ways that go beyond their fiber content, with new research highlighting the potential importance of certain indigestible plant proteins.

Two studies led by researchers at Princeton University found that plant fiber and a group of indigestible plant proteins, described as “proteins imitating fiber” or Prif, can alter gut microbial activity and shift the production of metabolites linked to health.

Published in Proceedings of the National Academy of Sciences, one study examined phenol metabolites produced when gut bacteria break down amino acids. Some, including phenylpropionate and hippuric acid, have been associated with healthier metabolic outcomes, while others, such as p-cresol sulfate and phenol sulfate, have been linked to toxicity and poorer health outcomes.

Researchers found that fiber and Prif worked together to favor the production of beneficial phenols while reducing harmful ones. Fiber appeared to limit bacterial breakdown of the gut's mucus lining, while Prif provided microbes with more indigestible dietary protein to process.

The findings suggest that these plant proteins could represent an overlooked component of a healthy diet. Researchers said they may eventually deserve attention alongside fiber when evaluating the nutritional benefits of plant-based foods.

A second study, published in Nature Metabolism, challenged another long-standing assumption: that phenol and indole metabolites circulating in the body are produced exclusively by gut bacteria. Using isotope tracing in animals and human cells, researchers found that mammalian metabolism can also produce several of these compounds.

Some metabolites remained at high levels even after antibiotics disrupted the gut microbiome, supporting the role of the body's own metabolism. In contrast, metabolites produced exclusively by bacteria declined following antibiotic treatment.

Together, the studies provide new insight into how plant foods, gut bacteria and human metabolism interact. The findings could eventually help scientists develop more precise dietary and microbiome-based strategies for preventing or managing disease, although further research is needed to determine whether the effects seen in experimental models translate directly to human health.

REFERENCE:

1.Jenna E. AbuSalim, et al.; Digestion-resistant proteins support the healthy metabolite profiles associated with plant-based diets. Proceedings of the National Academy of Sciences, 2026; 123 (32) DOI: 10.1073/pnas.2605226123

2.Jenna E. AbuSalim, et al.; Host metabolism can produce many indoles and phenols independently of the microbiome. Nature Metabolism, 2026; 8 (7): 1528 DOI: 10.1038/s42255-026-01550-8

Cocoa Polyphenols May Benefit Mood and Brain Health, Research Suggests

A recent review published in Frontiers in Nutrition suggests that cocoa polyphenols may support brain health through effects on mood, blood flow, inflammation and the gut-brain axis. However, researchers caution that evidence for cognitive benefits remains mixed and larger clinical trials are needed.

Cocoa is rich in flavanols and procyanidins, compounds with antioxidant and anti-inflammatory properties. Some cocoa-derived compounds may reach the brain and influence pathways involved in neuroplasticity, cerebral blood flow and cognitive function. The flavanol epicatechin, for example, has improved learning and spatial memory in animal studies.

Human studies provide some evidence that cocoa may benefit emotional well-being. Trials involving dark chocolate or cocoa polyphenols have reported reductions in depressive symptoms, improvements in mood and greater feelings of calmness and contentment. One study found that 30 grams per day of 85% dark chocolate improved negative affect in healthy participants.

Researchers also observed changes in gut bacteria, including increased microbial diversity and changes. However, these findings show associations and do not prove that microbiome changes directly caused mood improvements.

Animal research has consistently linked cocoa interventions with improved memory, hippocampal neurogenesis and synaptic plasticity. Human studies, however, have produced less consistent results.

Some research has reported improvements in processing speed, verbal episodic memory, executive function and cognitive flexibility after cocoa or dark chocolate consumption. Other trials found no meaningful improvements in attention, working memory, reaction time or cognitive accuracy.

Overall, the review found the strongest evidence for cocoa polyphenols relates to mood and depressive symptoms, while evidence for broader cognitive benefits remains heterogeneous. Researchers say future studies should use larger participant groups, standardized cocoa preparations and longer follow-up periods.

The findings suggest that cocoa polyphenols could have neuroprotective potential, but their role in preventing or treating neurological and depressive disorders remains to be established.

REFERENCE: Li L, Tong HHY (2026). Cocoa polyphenols in brain health: BDNF/CREB-mediated mechanisms in depression, cognition, and the gut–brain axis. Frontiers in Nutrition, 13, 1859145. DOI: 10.3389/fnut.2026.1859145,